000			02199 a2200577 4500
005			20250515185916.0
264		0	_c20100126
008			201001s 0 0 eng d
022			_a1521-009X
024	7		_a10.1124/dmd.109.029728 _2doi
040			_aNLM _beng _cNLM
100	1		_aBackman, Janne T
245	0	0	_aCYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe. _h[electronic resource]
260			_bDrug metabolism and disposition: the biological fate of chemicals _cDec 2009
300			_a2359-66 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aArea Under Curve
650	0	4	_aAryl Hydrocarbon Hydroxylases _xantagonists & inhibitors
650	0	4	_aBiotransformation
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aCross-Over Studies
650	0	4	_aCytochrome P-450 CYP2C8
650	0	4	_aDrug Interactions
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGemfibrozil _xadministration & dosage
650	0	4	_aGenotype
650	0	4	_aGlucuronates _xblood
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aHypolipidemic Agents _xadministration & dosage
650	0	4	_aLiver-Specific Organic Anion Transporter 1
650	0	4	_aMale
650	0	4	_aModels, Biological
650	0	4	_aMolecular Probes _xadministration & dosage
650	0	4	_aOrganic Anion Transporters _xgenetics
650	0	4	_aPhenotype
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aHonkalammi, Johanna
700	1		_aNeuvonen, Mikko
700	1		_aKurkinen, Kaisa J
700	1		_aTornio, Aleksi
700	1		_aNiemi, Mikko
700	1		_aNeuvonen, Pertti J
773	0		_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 37 _gno. 12 _gp. 2359-66
856	4	0	_uhttps://doi.org/10.1124/dmd.109.029728 _zAvailable from publisher's website
999			_c19170517 _d19170517